Evidence map›Paper›PMID 38804369›Full record

ReviewEpigenomes2024

Emerging Approaches to Profile Accessible Chromatin from Formalin-Fixed Paraffin-Embedded Sections.

Vishnu Udayakumaran Nair Sunitha Kumary, Bryan J Venters, Karthikeyan Raman, Sagnik Sen, Pierre-Olivier Estève, Martis W Cowles, Michael-Christopher Keogh, Sriharsa Pradhan

Abstract readReview
In one paragraph

Review in Epigenomes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Vishnu Udayakumaran Nair Sunitha KumaryEpiCypher Inc., Durham, NC 27709, USA.ORCID 0000-0001-5112-1011
Bryan J VentersEpiCypher Inc., Durham, NC 27709, USA.ORCID 0000-0002-4607-0587
Karthikeyan RamanGenome Biology Division, New England Biolabs, Ipswich, MA 01983, USA.ORCID 0009-0003-3817-5551
Sagnik SenGenome Biology Division, New England Biolabs, Ipswich, MA 01983, USA.ORCID 0000-0002-3362-1677
Pierre-Olivier EstèveGenome Biology Division, New England Biolabs, Ipswich, MA 01983, USA.
Martis W CowlesEpiCypher Inc., Durham, NC 27709, USA.
Michael-Christopher KeoghEpiCypher Inc., Durham, NC 27709, USA.ORCID 0000-0002-2219-8623
Sriharsa PradhanGenome Biology Division, New England Biolabs, Ipswich, MA 01983, USA.ORCID 0000-0003-1710-0588

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nucleosomes are non-uniformly distributed across eukaryotic genomes, with stretches of 'open' chromatin strongly associated with transcriptionally active promoters and enhancers. Understanding chromatin accessibility patterns in normal tissue and how they are altered in pathologies can provide critical insights to development and disease. With the advent of high-throughput sequencing, a variety of strategies have been devised to identify open regions across the genome, including DNase-seq, MNase-seq, FAIRE-seq, ATAC-seq, and NicE-seq. However, the broad application of such methods to FFPE (formalin-fixed paraffin-embedded) tissues has been curtailed by the major technical challenges imposed by highly fixed and often damaged genomic material. Here, we review the most common approaches for mapping open chromatin regions, recent optimizations to overcome the challenges of working with FFPE tissue, and a brief overview of a typical data pipeline with analysis considerations.

Indexed as

chromatinFFPEnucleosomenucleosome-depleted regionnucleosome-free region

Identifiers

PMID38804369
PMCPMC11130958

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.